Concordance of Drug-resistance Profiles Between Persons With Drug-resistant Tuberculosis and Their Household Contacts: A Systematic Review and Meta-analysis
Open Access
- 25 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (2), 250-263
- https://doi.org/10.1093/cid/ciaa613
Abstract
Household contacts of patients with drug-resistant tuberculosis (TB) are at high risk for being infected with Mycobacterium tuberculosis and for developing TB disease. To guide regimen composition for the empirical treatment of TB infection and disease in these household contacts, we estimated drug-resistance profile concordance between index patients with drug-resistant TB and their household contacts. We performed a systematic review and meta-analysis of studies published through 24 July 2018 that reported resistance profiles of drug-resistant TB index cases and secondary cases within their households. Using a random-effects meta-analysis, we estimated resistance profile concordance, defined as the percentage of secondary cases whose M. tuberculosis strains were resistant to the same drugs as strains from their index cases. We also estimated isoniazid/rifampin concordance, defined as whether index and secondary cases had identical susceptibilities for isoniazid and rifampin only. We identified 33 eligible studies that evaluated resistance profile concordance between 484 secondary cases and their household index cases. Pooled resistance profile concordance was 54.3% (95% confidence interval [CI], 40.7–67.6%; I2 = 85%). Pooled isoniazid/rifampin concordance was 82.6% (95% CI, 72.3–90.9%; I2 = 73%). Concordance estimates were similar in a subanalysis of 16 studies from high-TB-burden countries. There were insufficient data to perform a subanalysis among pediatric secondary cases. Household contacts of patients with drug-resistant TB should receive treatment for TB infection and disease that assumes that they, too, are infected with a drug-resistant M. tuberculosis strain. Whenever possible, drug susceptibility testing should be performed for secondary cases to optimize regimen composition.Funding Information
- US National Institutes of Health (5K01TW010829, 5R01GM122876)
- UK Medical Research Council
- UK Department for International Development (MR/R007942/1)
- National Institutes of Health
This publication has 46 references indexed in Scilit:
- Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the PhilippinesBMC Infectious Diseases, 2013
- Contact investigation for tuberculosis: a systematic review and meta-analysisEuropean Respiratory Journal, 2012
- Drug-Resistant Tuberculosis Transmission and Resistance Amplification within FamiliesEmerging Infectious Diseases, 2012
- Discordant Drug Susceptibility For Mycobacterium tuberculosis within FamiliesThe Pediatric Infectious Disease Journal, 2012
- Transmission of tuberculosis within family-householdsJournal of Infection, 2012
- Transmission of Mycobacterium tuberculosis in a Family Proved by GenotypingJournal of the Formosan Medical Association, 2007
- Spread of Strain W, a Highly Drug‐Resistant Strain ofMycobacterium tuberculosis, Across the United StatesClinical Infectious Diseases, 1999
- Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Isoniazid-resistant tuberculosis. A community outbreak and report of a rifampin prophylaxis failureJAMA, 1985
- Primary Drug-Resistant TuberculosisThe New England Journal of Medicine, 1970